Glenmark Pharma launches nasal spray for treatment of Covid patients in India

Glenmark Pharma launches nasal spray for treatment of Covid patients in India

by admin- Wednesday, February 9th, 2022 08:15:56 PM

Glenmark Pharmaceuticals (Glenmark) introduced launch of its Nitric Oxide Nasal Spray under the logo name FabiSpray in India; for the treatment of adult sufferers with COVID-19 who have high chance of development of the disease. Glenmark in advance acquired production and advertising and marketing approval from the Drugs Controller General of India (DCGI) for NONS as part of the expanded approval process.

News Updates